New Drug Combo Approved for Hard-to-Treat Diffuse Large B-Cell Lymphoma

Article Fact Checked

Medically Reviewed

/ Updated December 29th, 2020

New Drug Combo Approved for Hard-to-Treat Diffuse Large B-Cell Lymphoma

NOW
PLAYING
"A Second Opportunity at Life"-- Maribel Ramos Is Thriving 5 Years After Experimental Immunotherapy for Triple-Negative Breast Cancer
NOW
PLAYING
Former Senator Bob Dole, 97, Has Lung Cancer-- After His Prostate Cancer, He Helped Remove the Stigma of Erectile Dysfunction
NOW
PLAYING
New Acute Myeloid Leukemia (AML) Maintenance Treatment Extends Patients’ Lives
NOW
PLAYING
Leukemia Survivor Says Symptoms Were First Dismissed as “Teen Hormones” & Now Has Early Menopause from Treatment; “I Kept Getting Told to Change My Lifestyle”
NOW
PLAYING
Woman Who Shared Intimate Moments on TikTok As She Battled Stage 4 Lymphoma, During Pandemic Lockdown, Gives Tips on How To Cope
NOW
PLAYING
A Former Paramedic, 48, Is Tragically Diagnosed with Advanced Lung Cancer After an 8-Month Delay to See His Doctor Because of COVID-19

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.